AI is creating new opportunities across life sciences and healthcare, from drug discovery and genomics to medical imaging, clinical documentation and patient engagement. As adoption grows, these applications are also placing new demands on the technology environments that support them.

Drug discovery relies on large volumes of scientific data and advanced simulations. Medical imaging requires significant processing capabilities and specialized tools. Clinical applications bring additional considerations around security, privacy and compliance. The rise of multimodal models and Agentic AI is adding further complexity.

For many organizations, however, the bigger challenge is taking successful AI experiments into production and delivering reliable, repeatable outcomes at enterprise scale.

Doing that requires a foundation that connects infrastructure, data, software, security and operations while supporting governance and long-term economic viability.

This is where HCLTech AI Factory, advanced by AMD, plays an important role.

Building the foundation for healthcare AI

As AI becomes more deeply embedded in research, clinical and operational environments, the underlying technology choices become increasingly important.

HCLTech AI Factory, advanced by AMD, brings together capabilities to build, deploy and manage AI at scale. AMD technologies form an important part of that foundation, with AMD Instinct GPUs, AMD EPYC CPUs and AMD ROCm software supporting demanding AI and scientific workloads.

This is particularly relevant in life sciences and healthcare, where organizations are working with diverse types of data and increasingly specialized models. Scientific applications such as protein modeling, molecular simulation and drug discovery can require substantial processing capabilities, while multimodal and Agentic AI introduce new demands as they move into production.

The objective is to create an environment in which organizations can match technology to the requirements of their AI initiatives and scale those initiatives as demand grows.

Making the economics of AI sustainable

As organizations move beyond experimentation, economics becomes a critical part of the AI conversation.

A promising proof of concept does not necessarily translate into a sustainable enterprise deployment. Training, inference and ongoing operations all contribute to cost, particularly as models become more complex and AI is applied across a growing number of business and research processes.

For life sciences and healthcare organizations, this matters because many of the most promising applications involve large datasets and intensive scientific processing.

The underlying architecture can therefore have a direct bearing on the business case for AI. Efficient use of resources and the ability to support different requirements without unnecessary complexity can help organizations manage the long-term economics of adoption.

The value of open architecture

Life sciences and healthcare technology environments often span research platforms, clinical systems and operational technologies. As AI becomes part of these environments, enterprises need to integrate new capabilities without creating another isolated technology layer.

AMD ROCm provides an open software platform for AI and high-performance computing, with support for widely adopted technologies such as PyTorch and Kubernetes-based deployment, helping organizations develop and scale AI workloads. 

Within HCLTech AI Factory, advanced by AMD, this openness helps enterprises work across different models and technology environments as their requirements evolve.

For healthcare organizations, that flexibility is important. The models being used today will continue to change. New applications will emerge and the technology required to support them will evolve. An open approach gives enterprises greater flexibility as models, tools and infrastructure requirements evolve.

Applying AI across life sciences and healthcare

The value of this foundation becomes clearer when considered against the range of AI workloads emerging across the healthcare ecosystem.

In pharmaceutical research, AI is being explored for areas such as target identification, molecular modeling and drug discovery. Scientific computing capabilities can support workloads involving protein modeling and molecular simulation, where large datasets and substantial processing power are required.

Medical imaging is another important area. AI models can assist with image-intensive workloads that require specialized frameworks and significant compute capacity. Across the broader healthcare environment, MedTech organizations are embedding intelligence into connected devices and diagnostic solutions.

Health insurers can apply AI to areas such as claims and customer engagement, while healthcare providers can use it for clinical documentation, workflow support and reducing administrative burden.

The requirements differ across these applications, which is why the underlying AI foundation needs to accommodate different models, data types and compute demands while maintaining enterprise requirements around security and governance.

Moving healthcare AI into production

The next phase of healthcare AI will be defined by its ability to turn promising ideas into capabilities that can operate reliably across the enterprise and deliver measurable outcomes over time.

Technology is one part of that transition. Organizations also need the governance, operational processes and expertise required to manage AI throughout its lifecycle.

HCLTech AI Factory, advanced by AMD, brings these elements together, combining technology with advisory, assessment, deployment and operational capabilities to support the journey from experimentation to production.

Together with AMD, we help life sciences and healthcare organizations establish that foundation so they can scale AI across research, clinical and operational environments.